Now, who decides what kind of evidence qualifies as "convincing"?
"The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate. The evidence of adverse events following immunisation with the MM vaccine cannot be separated from its role in preventing the target diseases."
Discussion